NSN 6505-01-212-8750
Part Details | METOCLOPRAMIDE ORAL SOLUTION
6505-01-212-8750
Alternate Parts: NDC00472500660, NDC00472-5006-60, NDC00472045416, NDC00472-0454-16, NDC00054356363, NDC00054-3563-63, NDC00603143558, NDC00603-1435-58, NDC00093610516, NDC00093-6105-16, NDC60432062216, NDC60432-0622-16, NDC00121057616, NDC00121-0576-16, NDC00031670625, NDC00031-6706-25, 670625, 6706-25, REGLAN SYRUP, REGLAN, NDC00364219516, NDC00364-2195-16, NDC54838050880, NDC54838-0508-80, 6505-01-212-8750, 01-212-8750, 6505012128750, 012128750
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | JUL 19, 1985 | 01-212-8750 | 48143 ( METOCLOPRAMIDE ORAL SOLUTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-212-8750
Part Number | Cage Code | Manufacturer |
---|---|---|
NDC00472-5006-60 | 1SFA8 | ALPHARMA US PHARMACEUTICALS DIVISIONDBA ALPHARMA |
NDC00472-0454-16 | 1SFA8 | ALPHARMA US PHARMACEUTICALS DIVISIONDBA ALPHARMA |
NDC00054-3563-63 | 34471 | BOEHRINGER INGELHEIM ROXANE, INC.DIV SUB OF BOEHRINGER INGELHEIM CORP |
NDC00603-1435-58 | 0ET99 | GENERICS BIDCO I, LLCDBA PAR PHARMACEUTICAL |
NDC00093-6105-16 | 80608 | LEMMON CO |
NDC60432-0622-16 | 00QD1 | MORTON GROVE PHARMACEUTICALS INC. |
NDC00121-0576-16 | 61181 | PHARMACEUTICAL ASSOCIATES, INC.DBA PAI |
NDC00031-6706-25 | 04516 | ROBINS A H CO INCGOVERNMENT SALES |
6706-25 | 04516 | ROBINS A H CO INCGOVERNMENT SALES |
REGLAN SYRUP | 04516 | ROBINS A H CO INCGOVERNMENT SALES |
REGLAN | 04516 | ROBINS A H CO INCGOVERNMENT SALES |
NDC00364-2195-16 | 0PTT8 | SCHEIN PHARMACEUTICAL INC |
NDC54838-0508-80 | 03EY5 | SILARX PHARMACEUTICALS INC |
Technical Data | NSN 6505-01-212-8750
Characteristic | Specifications |
---|---|
ACTIVE MEDICAMENT MEDICINAL STRENGTH | CS5.000 MILLIGRAMS METOCLOPRAMIDE |
PRIMARY CONTAINER TYPE | BOTTLE |
PRIMARY CONTAINER CONTENT QUANTITY | T1.000$JML473.000 |
SPECIAL FEATURES | PALATABLE; SUGAR-FREE |
PART NAME ASSIGNED BY CONTROLLING AGENCY | METOCLOPRAMIDE HYDROCHLORIDE SYRUP SUGAR-FREE 1PT/473ML BT |